Organisms are equipped with endogenous control mechanisms to inhibit JAK/STAT signaling molecules, such as the SOCS family; however, these regulatory pathways lose their effectiveness in patients with autoimmune diseases. This evidence concerns the gene CISH and autoimmune disease.